Androgen treatment mitigates hematopoietic cell telomere attrition in vivo (2012)
- Authors:
- Autor USP: RODRIGUES, RODRIGO DO TOCANTINS CALADO DE SALOMA - FMRP
- Unidade: FMRP
- Subjects: CÉLULAS SANGUÍNEAS; MEDULA ÓSSEA; HORMÔNIOS SEXUAIS; EXPRESSÃO GÊNICA
- Language: Inglês
- Imprenta:
- Publisher place: Washington
- Date published: 2012
- Source:
- Conference titles: Annual Meeting of the American Society of Hematology (ASH)
-
ABNT
CHEN, Jichun et al. Androgen treatment mitigates hematopoietic cell telomere attrition in vivo. Blood. Washington: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. . Acesso em: 28 dez. 2025. , 2012 -
APA
Chen, J., Desierto, M. J., Dent, J. J., Bachman, M. J., Calado, R. T., Stratakis, C. A., & Young, N. S. (2012). Androgen treatment mitigates hematopoietic cell telomere attrition in vivo. Blood. Washington: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. -
NLM
Chen J, Desierto MJ, Dent JJ, Bachman MJ, Calado RT, Stratakis CA, Young NS. Androgen treatment mitigates hematopoietic cell telomere attrition in vivo. Blood. 2012 ; 120( 21):[citado 2025 dez. 28 ] -
Vancouver
Chen J, Desierto MJ, Dent JJ, Bachman MJ, Calado RT, Stratakis CA, Young NS. Androgen treatment mitigates hematopoietic cell telomere attrition in vivo. Blood. 2012 ; 120( 21):[citado 2025 dez. 28 ] - Age-adjusted recipient pretransplantation telomere length and treatment-related mortality after hematopoietic stem cell transplantation
- Telomeres in disease
- Células reprogramadas. [Depoimento a Hérika Dias e Luis Ribeiro]
- Telomere shortening in hepatocyte proliferation and predisposition to alcohol-induced steatosis
- Efficacy and safety of eltrombopag combined with cyclosporine as first-line therapy in adults with severe acquired aplastic anemia: results of the interventional phase 2 single-arm soar study
- A novel homozygous RTEL1 variant in a consanguineous Lebanese family: phenotypic heterogeneity and disease anticipation
- GATA2 mutation in long stand Mycobacterium kansasii infection, myelodysplasia and MonoMAC syndrome: a case-report
- Molecular characterization of clinical response and relapse in patients with IDH1m ND-AML treated with Ivo+AZA in the aGILE study
- BCL2A1a over-expression in murine hematopoietic stem and progenitor cells decreases apoptosis and results in hematopoietic transformation
- Targeting complement to treat paroxysmal nocturnal hemoglobinuria (PNH)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
